Lobbying registrant

LMH STRATEGIC SOLUTIONS

Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections16with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

Lobbied forevidence
Mirum Pharmaceuticals, Inc.LDA RR 2026 third quarter · Health issues · Sep 7, 2026
Lobbied forevidence
ARDELYX, INC.LDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
Lobbied forevidence
Natera, Inc.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
Rezolute, Inc.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied forevidence
GSK plcLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
Lobbied forevidence
Travere Therapeutics, Inc.LDA Q1 2026 first quarter · Pharmacy · Aug 26, 2026
Lobbied forevidence
PTC THERAPEUTICS, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
Lobbied forevidence
IONIS PHARMACEUTICALS INCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
Lobbied forevidence
Savara IncLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
Lobbied forevidence
INCYTE CORPLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
Lobbied forevidence
BICYCLE THERAPEUTICS PLCLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
Lobbied forevidence
Alkermes plc.LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
REGENXBIO Inc.LDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
Lobbied forevidence
INSMED IncLDA RR 2026 second quarter · Trade · Aug 26, 2026
Lobbied forevidence
NeuroPace IncLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
ALNYLAM PHARMACEUTICALS, INC.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026